The importance of pets as reservoirs of resistant Enterococcus strains, with special reference to vancomycin.

The purpose of the present study was to determine the prevalence of antibiotic resistance, with special attention to vancomycin, in 104 strains of Enterococcus, which is the sentinel bacterium isolated from dog and cat faeces samples. The phenotypic characterization of the isolates classified them as E. faecium (58%), E. avium (41%) and E. faecalis (1%). Sensitivity testing used the diffusion method according to the recommendations of CASFM (Comite de l'Antibiogramme de la Société Française de Microbiogie), to oxacillin, amoxycillin, amoxycilin + clavulanic acid, ampicillin, piperacillin, cefoperazone, imipenem, enrofloxacin, ciprofloxacin, ofloxacin, nalidixic acid, tetracycline, lincomycin, erythromicin and vancomycin. Minimum inhibitory concentration (MIC) determination by E test revealed a MIC to vancomycin of between 0.5 microg/ml and 3 microg/ml. All the strains were resistant to nalidixic acid, erythromycin, cefoperazone and oxacillin. We detected resistance to amoxycillin + clavulanic acid in 1.9% of isolates, to amoxycillin in 4.8%, to piperacillin in 13.5%, and to ampicillin in 21.2% of strains. A high prevalence of antibiotic resistance to lincomycin, tetracycline, enrofloxacin, ciprofloxacin and ofloxacin was found in 98.1%, 95.2%, 76.9%, 73.1% and 64.4% of strains, respectively. Resistance to vancomycin was not found, which indicates that there is no transmission risk of vancomycin-resistant enterococcal strains to man or transfer of their resistance genes to other bacteria belonging to the endogenous flora of humans.

[1]  L. Rice Emergence of vancomycin-resistant enterococci. , 2001, Emerging infectious diseases.

[2]  F. Aarestrup,et al.  Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Example of an ongoing project within the European research programme. , 2000, International journal of antimicrobial agents.

[3]  F. Tenover Implications of vancomycin-resistant Staphylococcus aureus. , 1999, The Journal of hospital infection.

[4]  A. Blanch,et al.  Identification of Enterococcus spp. with a Biochemical Key , 1999, Applied and Environmental Microbiology.

[5]  G. French Enterococci and vancomycin resistance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Auckenthaler,et al.  Characterization of Glycopeptide-Resistant Enterococci from a Swiss Hospital , 1998, Journal of Clinical Microbiology.

[7]  M. Gilmore,et al.  Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. , 1998, Emerging infectious diseases.

[8]  M. Zervos,et al.  Epidemiologic Evaluation of Antimicrobial Resistance in Community-Acquired Enterococci , 1998, Journal of Clinical Microbiology.

[9]  T. Hodge,et al.  Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele. , 1997, Emerging infectious diseases.

[10]  F. Tenover,et al.  Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. , 1997, Emerging infectious diseases.

[11]  R. Leclercq,et al.  EMERGING PROBLEMS WITH ENTEROCOCCAL INFECTIONS , 1996 .

[12]  N Woodford,et al.  Current perspectives on glycopeptide resistance , 1995, Clinical microbiology reviews.

[13]  J. Bates,et al.  Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. , 1994, The Journal of antimicrobial chemotherapy.

[14]  V. Yu Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. , 1981, Annals of internal medicine.

[15]  Mac Faddin,et al.  Biochemical tests for identification of medical bacteria , 1976 .